Matthew Stratton

Mr. Matthew Stratton


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMatthew Stratton
Matthew Stratton
GTGrant Tinsley
Grant Tinsley
MAMichaela G. Alesi
Michaela G. Alesi
GHGarrett M. Hester
Garrett M. Hester
AOAlex A. Olmos
Alex A. Olmos
TVTrisha VanDusseldorp
Trisha VanDusseldorp
Recently, interest in time-restricted feeding (TRF) has increased from reports highlighting improvements in body composition and muscular performance measures. Twenty-six recreationally active males were randomly assigned to either TRF (n = 13; ~22.9 years; 82.0 kg; 178.1 cm; 8 h eating window, 25% caloric deficit, 1.8 g/kg/day protein) or normal diet (ND; n = 13; ~22.5 years; 83.3 kg; 177.5 cm; normal meal pattern; 25% caloric deficit, 1.8 g/kg/day protein) groups. Participants underwent 4-weeks of supervised full body resistance training. Changes in body composition (fat mass (FM), fat free mass (FFM), and body fat percentage (BF%)), skeletal muscle cross sectional area (CSA) and muscle thickness (MT) of the vastus lateralis (VL), rectus femoris, (RF), and biceps brachii (BB) muscles, resting energy expenditure (REE), muscular performance, blood biomarkers, and psychometric parameters were assessed. Significant (p < 0.05) decreases were noted in BM, FM, BF%, testosterone, adiponectin, and REE, along with significant increases in BP1RM, LP1RM, VJHT, VJPP, VLCSA, BBCSA, and BBMT in both groups. Plasma cortisol levels were significantly elevated at post (p = 0.018) only in ND. Additionally, FFM was maintained equally between groups. Thus, a TRF style of eating does not enhance reductions in FM over caloric restriction alone during a 4-week hypocaloric diet.

31 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Scott ForbesScott Forbes
Scott Forbes
Darren CandowDarren Candow
Darren Candow
ASAbbie E Smith-Ryan
Abbie E Smith-Ryan
KHKatie Hirsch
Katie Hirsch
Mike RobertsMike Roberts
Mike Roberts
JLJonathan Little
Jonathan Little
High-intensity interval training (HIIT) involves short bursts of intense activity interspersed by periods of low-intensity exercise or rest. HIIT is a viable alternative to traditional continuous moderate-intensity endurance training to enhance maximal oxygen uptake and endurance performance. Combining nutritional strategies with HIIT may result in more favorable outcomes. The purpose of this narrative review is to highlight key dietary interventions that may augment adaptations to HIIT, including creatine monohydrate, caffeine, nitrate, sodium bicarbonate, beta-alanine, protein, and essential amino acids, as well as manipulating carbohydrate availability. Nutrient timing and potential sex differences are also discussed. Overall, sodium bicarbonate and nitrates show promise for enhancing HIIT adaptations and performance. Beta-alanine has the potential to increase training volume and intensity and improve HIIT adaptations. Caffeine and creatine have potential benefits, however, longer-term studies are lacking. Presently, there is a lack of evidence supporting high protein diets to augment HIIT. Low carbohydrate training enhances the upregulation of mitochondrial enzymes, however, there does not seem to be a performance advantage, and a periodized approach may be warranted. Lastly, potential sex differences suggest the need for future research to examine sex-specific nutritional strategies in response to HIIT.

27 July 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
TVTrisha VanDusseldorp
Trisha VanDusseldorp
KEKurt A. Escobar
Kurt A. Escobar
KJKelly E Johnson
Kelly E Johnson
MSMatthew Stratton
Matthew Stratton
Terence MoriartyTerence Moriarty
Terence Moriarty
Mermier ChristineMermier Christine
Mermier Christine
Fish oils (FOs) are rich in omega-3 long-chain polyunsaturated fatty acids, which have been purported to enhance recovery of muscular performance and reduce soreness post-exercise. However, the most effective FO dose for optimizing recovery remains unclear. The purpose of this investigation was to examine the effect of FO supplementation dosing on the recovery of measures of muscular performance, perceived soreness, and markers of muscle damage following a rigorous bout of eccentric exercise. Thirty-two college-aged resistance-trained males (~23.6 years, 71.6 kg, 172.1 cm) were supplemented with 2, 4, 6 g/day (G) FO or placebo (PL) for ~7.5 weeks. Following 7 weeks of supplementation, pre-exercise (PRE) performance assessments of vertical jump (VJ), knee extensor strength, 40-yard sprint, T-test agility, and perceived soreness were completed prior to a bout of muscle-damaging exercise and were repeated immediately post (IP), 1-, 2-, 4-, 24-, 48-, and 72-h (H) post-exercise. Repeated measures analysis of variance indicated a treatment × time interaction (p < 0.001) for VJ and perceived soreness, but no group differences were observed at any time point. VJ returned to PRE (54.8 ± 7.9 cm) by 1H (51.8 ± 6.5 cm, p = 0.112) for 6G, while no other groups returned to baseline until 48H. Lower soreness scores were observed in 6G compared to PL at 2H (mean difference [MD] = 2.74, p = 0.046), at 24H (MD: 3.45, p < 0.001), at 48H (MD = 4.45, p < 0.001), and at 72H (MD = 3.00, p = 0.003). Supplementation with 6G of FO optimized the recovery of jump performance and muscle soreness following a damaging bout of exercise.

13 August 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
GTGrant Tinsley
Grant Tinsley
PHPatrick S. Harty
Patrick S. Harty
MSMatthew Stratton
Matthew Stratton
MSMadelin R. Siedler
Madelin R. Siedler
CRChristian Rodriguez
Christian Rodriguez
Multivitamin/mineral (MVM) supplements are one of the most popular dietary supplement categories. The purpose of this analysis was to determine if a novel liposomal delivery mechanism improves mineral absorption from an MVM product. In a randomized crossover trial, 25 healthy participants (12 females, 13 males) completed two testing sessions in which blood samples were collected at baseline and 2, 4, and 6 h following the ingestion of either a liposomal MVM or a nutrient-matched standard MVM. Analysis of MVM products indicated an elemental iron content of 9.4 and 10.1 mg (~50% U.S. FDA Daily Value) and an elemental magnesium content of 22.0 and 23.3 mg (~5% U.S. FDA Daily Value) in the liposomal and standard MVM products, respectively. Blood samples were analyzed for concentrations of iron and magnesium using colorimetric assays. Changes in mineral concentrations were analyzed using linear mixed models, and pharmacokinetic parameters were compared between conditions. For iron, statistically significant condition × time interactions were observed for percent change from baseline (p = 0.002), rank of percent change from baseline (p = 0.01), and raw concentrations (p = 0.02). Follow-up testing indicated that the liposomal condition exhibited larger changes from baseline than the standard MVM condition at 4 (p = 0.0001; +14.3 ± 18.5% vs. −6.0 ± 13.1%) and 6 h (p = 0.0002; +1.0 ± 20.9% vs. −21.0 ± 15.3%) following MVM ingestion. These changes were further supported by a 50% greater mean incremental area under the curve in the liposomal condition (33.2 ± 30.9 vs. 19.8 ± 19.8 mcg/dL × 6 h; p = 0.02, Cohen’s d effect size = 0.52). In contrast, no differential effects for magnesium absorption were observed. In conclusion, iron absorption from an MVM product is enhanced by a liposomal delivery mechanism.

28 February 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
TVTrisha VanDusseldorp
Trisha VanDusseldorp
MSMatthew Stratton
Matthew Stratton
ABAlyssa Bailly
Alyssa Bailly
AHAlyssa J. Holmes
Alyssa J. Holmes
MAMichaela G. Alesi
Michaela G. Alesi
AMAndrew Modjeski
Andrew Modjeski
Methylliberine (Dynamine®; DYM) and theacrine (Teacrine®; TCR) are purine alkaloids purported to have similar neuro-energetic effects as caffeine. There are no published human safety data on DYM, and research on TCR is limited. The purpose of this study was to examine the effect of four weeks of DYM supplementation with and without TCR on cardiovascular function and blood biomarkers. One-hundred twenty-five men and women (mean age 23.0 yrs, height 169.7 cm, body mass 72.1 kg; n = 25/group) were randomly assigned to one of five groups: low-dose DYM (100 mg), high-dose DYM (150 mg), low-dose DYM with TCR (100 mg + 50 mg), high-dose DYM with TCR (150 mg + 25 mg), and placebo. Regardless of group and sex, significant main effects for time were noted for heart rate, systolic blood pressure, and QTc (p < 0.001), high-density lipoproteins (p = 0.002), mean corpuscular hemoglobin (p = 0.018), basophils (p = 0.006), absolute eosinophils (p = 0.010), creatinine (p = 0.004), estimated glomerular filtration rate (p = 0.037), chloride (p = 0.030), carbon dioxide (p = 0.023), bilirubin (p = 0.027), and alanine aminotransferase (p = 0.043), among others. While small changes were found in some cardiovascular and blood biomarkers, no clinically significant changes occurred. This suggests that DYM alone or in combination with TCR consumed at the dosages used in this study does not appear to negatively affect markers of health over four weeks of continuous use.

Verified
Journal Article
Open access
PDF file
RSRobert W. Smith
Robert W. Smith
PHPatrick S. Harty
Patrick S. Harty
MSMatthew Stratton
Matthew Stratton
ZRZad Rafi
Zad Rafi
CRChristian Rodriguez
Christian Rodriguez
GTGrant Tinsley
Grant Tinsley
Relatively few investigations have reported purposeful overfeeding in resistance-trained adults. This preliminary study examined potential predictors of resistance training (RT) adaptations during a period of purposeful overfeeding and RT. Resistance-trained males (n = 28; n = 21 completers) were assigned to 6 weeks of supervised RT and daily consumption of a high-calorie protein/carbohydrate supplement with a target body mass (BM) gain of ≥0.45 kg·wk−1. At baseline and post-intervention, body composition was evaluated via 4-component (4C) model and ultrasonography. Additional assessments of resting metabolism and muscular performance were performed. Accelerometry and automated dietary interviews estimated physical activity levels and nutrient intake before and during the intervention. Bayesian regression methods were employed to examine potential predictors of changes in body composition, muscular performance, and metabolism. A simplified regression model with only rate of BM gain as a predictor was also developed. Increases in 4C whole-body fat-free mass (FFM; (mean ± SD) 4.8 ± 2.6%), muscle thickness (4.5 ± 5.9% for elbow flexors; 7.4 ± 8.4% for knee extensors), and muscular performance were observed in nearly all individuals. However, changes in outcome variables could generally not be predicted with precision. Bayes R2 values for the models ranged from 0.18 to 0.40, and other metrics also indicated relatively poor predictive performance. On average, a BM gain of ~0.55%/week corresponded with a body composition score ((∆FFM/∆BM)*100) of 100, indicative of all BM gained as FFM. However, meaningful variability around this estimate was observed. This study offers insight regarding the complex interactions between the RT stimulus, overfeeding, and putative predictors of RT adaptations.